Major
Moderate
Slight
None
Can't tell
Side effects
Side effects as an overall problem
Side effects as an overall problem
Severity
Evaluations
Percentage
This item is relevant to you:
Severe
0
This item is relevant to you:
Moderate
0
This item is relevant to you:
Mild
0
This item is relevant to you:
None
1
Why patients stopped taking Zalcitabine (ddC)
Multiple reasons could be selected
Reason
Patients
Percentage
This item is relevant to you:
Doctor's advice
3
This item is relevant to you:
Side effects too severe
2
This item is relevant to you:
Course of treatment ended
1
This item is relevant to you:
Did not seem to work
1
This item is relevant to you:
Other
1
See
all
8 patients
who've
stopped taking Zalcitabine (ddC)
Duration
Stopped taking Zalcitabine (ddC)
Duration
Patients
Percentage
This item is relevant to you:
1 - 6 months
1
This item is relevant to you:
6 months - 1 year
1
This item is relevant to you:
1 - 2 years
1
This item is relevant to you:
2 - 5 years
5
Adherence
Adherence
Evaluations
Percentage
This item is relevant to you:
Always
1
1 evaluation from 1 patient
This item is relevant to you:
Usually
0
0 evaluations from 0 patients
This item is relevant to you:
Sometimes
0
0 evaluations from 0 patients
This item is relevant to you:
Never
taken as prescribed
0
0 evaluations from 0 patients
Burden
Burden
Evaluations
Percentage
This item is relevant to you:
Very
hard to take
0
0 evaluations from 0 patients
This item is relevant to you:
Somewhat
hard to take
1
1 evaluation from 1 patient
This item is relevant to you:
A little
hard to take
0
0 evaluations from 0 patients
This item is relevant to you:
Not at all
hard to take
0
0 evaluations from 0 patients
Cost per month
Cost per month
Evaluations
Percentage
This item is relevant to you:
$200+
0
0 evaluations from 0 patients
This item is relevant to you:
$100-199
0
0 evaluations from 0 patients
This item is relevant to you:
$50-99
1
1 evaluation from 1 patient
This item is relevant to you:
$25-49
0
0 evaluations from 0 patients
This item is relevant to you:
< $25
0
0 evaluations from 0 patients
This item is relevant to you:
Not specified
0
0 evaluations from 0 patients
What people switch to and from
Patients
started
taking
Zalcitabine (ddC)
after stopping:
Treatment
Patients
Percentage
This item is relevant to you:
Nevirapine (NVP)
(Viramune )
1
Last updated:
April 25, 2026